Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 253.710K |
Day Range | - - - |
52 Wk Range | 1.040 - 5.240 |
Market Cap | $32.472M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 0.87% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Protara Therapeutics (NASDAQ: TARA) through any online brokerage.
Other companies in Protara Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), OncoCyte (NASDAQ:OCX) and Palatin Techs (AMEX:PTN).
The latest price target for Protara Therapeutics (NASDAQ: TARA) was reported by Oppenheimer on Monday, April 22, 2024. The analyst firm set a price target for 30.00 expecting TARA to rise to within 12 months (a possible 956.34% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Protara Therapeutics (NASDAQ: TARA) is $2.84 last updated April 24, 2024 at 5:22 PM EDT.
There are no upcoming dividends for Protara Therapeutics.
Protara Therapeutics’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Protara Therapeutics.
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.